Global Antiparasitic Drugs Market to Exhibit Significant Increase in Demand With Extention of COVID-19 Crisis

Antiparasitic drugs, such as anthelmintics, antiporozoals and some other agents, are used in the treatment of parasitic infectious diseases. According to WHO reports, 1.5 billion people worldwide are affected by the parasitic disease in March 2020. These diseases include gastrointestinal disorders, anemia, waste, and cognitive and development delays in children and other infections. Of the 1.5 billion people affected by parasitic infectious diseases, 24 percent of people worldwide are infected with soil-borne helminth infections. Some parasitic infections are life-threatening, whereas others cause discomfort in a healthy lifestyle.

The global demand for the antiparasitic drugs market was estimated at US$7,227.9 million in 2019 and is projected to have a CAGR of 5.2 percent over the forecast years (2020–2027).

Buy Now With Covid-19 Analysis and Updated Information@ https://www.coherentmarketinsights.com/insight/buy-now/3782

Global Antiparasitic Drugs Market- Regional Analysis

On a geographic basis, the global demand for antiparasitic drugs market is segmented into North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Africa is projected to hold a dominant market place among regions due to a growing risk of malaria in the region. For example, according to the WHO, about 92% of malaria cases worldwide occur in sub-Saharan Africa. In 2017, the WHO also reported that of the five countries that accounted for almost half of all malaria cases globally, four countries came from Africa, including Nigeria (25%), the Democratic Republic of Congo (11 percent), Mozambique (5 percent) and Uganda (4 percent ).

For Further Report Related Query@ https://www.coherentmarketinsights.com/insight/talk-to-analyst/3782

Global Antiparasitic Drugs Market - Competitive Landscape

Key players operating in the global antiparasitic drugs market include Ipca Laboratories Ltd., Zydus Cadila, Merck KGaA, Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG, Alvizia Health Care, Bayer AG, Roche Inc., Arbor Pharmaceuticals Inc., Sanofi, AstraZeneca plc., and Alkem Laboratories Limited.

Mr. Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Coherent Market Insights (CMI) is a global market intelligence and consulting organization focused on assisting plethora of clients achieve transformational growth by helping them make critical business decisions.

This release was published on openPR.